These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7363908)

  • 1. Gaucher disease--Norrbottnian type. I. General clinical description.
    Dreborg S; Erikson A; Hagberg B
    Eur J Pediatr; 1980 Mar; 133(2):107-18. PubMed ID: 7363908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norrbottnian clinical variant of Gaucher disease in Southern Italy.
    Sestito S; Filocamo M; Ceravolo F; Falvo F; Grisolia M; Moricca MT; Cantaffa R; Grossi S; Strisciuglio P; Concolino D
    J Hum Genet; 2017 Apr; 62(4):507-511. PubMed ID: 28003644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
    Svennerholm L; Dreborg S; Erikson A; Groth CG; Hillborg PO; Håkansson G; Nilsson O; Tibblin E
    Prog Clin Biol Res; 1982; 95():67-94. PubMed ID: 6812091
    [No Abstract]   [Full Text] [Related]  

  • 5. Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation.
    Svennerholm L; Erikson A; Groth CG; Ringdén O; Månsson JE
    Dev Neurosci; 1991; 13(4-5):345-51. PubMed ID: 1817041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease--Norrbottnian type. Neurodevelopmental, neurological, and neurophysiological aspects.
    Blom S; Erikson A
    Eur J Pediatr; 1983 Sep; 140(4):316-22. PubMed ID: 6628452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type.
    Erikson A; Groth CG; Månsson JE; Percy A; Ringdén O; Svennerholm L
    Acta Paediatr Scand; 1990; 79(6-7):680-5. PubMed ID: 2386062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of the gene for the juvenile type of Gaucher disease in Sweden.
    Iselius L; Hillborg PO; Lindsten J
    Acta Paediatr Scand; 1989 Jul; 78(4):592-6. PubMed ID: 2782076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy.
    Kyllerman M; Conradi N; Månsson JE; Percy AK; Svennerholm L
    Acta Paediatr Scand; 1990 Apr; 79(4):448-53. PubMed ID: 2349880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease--Norrbottnian type. Ocular abnormalities.
    Erikson A; Wahlberg I
    Acta Ophthalmol (Copenh); 1985 Apr; 63(2):221-5. PubMed ID: 4003050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher disease (Norrbottnian type III): probable founders identified by genealogical and molecular studies.
    Dahl N; Hillborg PO; Olofsson A
    Hum Genet; 1993 Nov; 92(5):513-5. PubMed ID: 8244344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease.
    Erikson A; Aström M; Månsson JE
    Neuropediatrics; 1995 Aug; 26(4):203-7. PubMed ID: 8544959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.
    Zimran A; Kay A; Gelbart T; Garver P; Thurston D; Saven A; Beutler E
    Medicine (Baltimore); 1992 Nov; 71(6):337-53. PubMed ID: 1435229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic studies of five fatal cases of Japanese Gaucher disease type 1.
    Ida H; Rennert OM; Ito T; Maekawa K; Eto Y
    Acta Paediatr Jpn; 1996 Jun; 38(3):233-6. PubMed ID: 8741312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease (type III): intellectual profile.
    Erikson A; Karlberg J; Skogman AL; Dreborg S
    Pediatr Neurol; 1987; 3(2):87-91. PubMed ID: 3508057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease.
    Conradi NG; Kalimo H; Sourander P
    Acta Neuropathol; 1988; 75(4):385-90. PubMed ID: 3364161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological findings in the Norrbottnian type of Gaucher disease.
    Tibblin E; Dreborg S; Erikson A; Håkansson G; Svennerholm L
    Eur J Pediatr; 1982 Nov; 139(3):187-91. PubMed ID: 7160406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
    Fairley C; Zimran A; Phillips M; Cizmarik M; Yee J; Weinreb N; Packman S
    J Inherit Metab Dis; 2008 Dec; 31(6):738-44. PubMed ID: 18979180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
    Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
    Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease: variability in phenotype among siblings.
    Amato D; Stachiw T; Clarke JT; Rivard GE
    J Inherit Metab Dis; 2004; 27(5):659-69. PubMed ID: 15669682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.